• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-4 和白细胞介素-13 不参与白细胞介素-31 诱导的小鼠瘙痒相关搔抓行为。

IL-4 and IL-13 are not involved in IL-31-induced itch-associated scratching behaviour in mice.

机构信息

Department of Dermatology, Dokkyo Medical University Saitama Medical Center, Saitama, Japan.

出版信息

Exp Dermatol. 2024 Jun;33(6):e15115. doi: 10.1111/exd.15115.

DOI:10.1111/exd.15115
PMID:38855893
Abstract

Itchy skin or pruritus is a common cutaneous symptom that causes an urge to scratch, and the role of interleukins (IL) in itchy skin has been widely studied. IL-4 and IL-13 are known to induce chronic itch. Similarly, the direct role of IL-31 in inducing itch has been demonstrated in clinical situations such as atopic dermatitis and prurigo nodularis. Moreover, IL-4 receptor α antibodies (dupilumab) and IL-31 receptor A antibodies (nemolizumab) inhibit pruritus. However, the interplay between these ILs in pruritus remains unclear. Therefore, we investigated the reciprocal effects of these cytokines on pruritus in mice. The intradermal administration of IL-31 induced itch-associated scratching behaviour in a dose-dependent manner. Interestingly, the amount of IL-31 and IL-4/IL-13, co-administration or 30 min pre-administration of IL-4/IL-13 and intradermal or intravenous pre-administration of IL-4 did not affect IL-31-induced itch-associated scratching behaviour when it was observed for 30 min, 2 h, 24 h or 48 h. Pre-administration of neutralising antibodies against IL-4 and IL-13 also did not affect IL-31-induced itch-associated scratching behaviour. These results suggest that IL-31 can induce itching independently of IL-4 and IL-13 in vivo.

摘要

皮肤瘙痒或瘙痒是一种常见的皮肤症状,会引起搔抓的冲动,白细胞介素(IL)在皮肤瘙痒中的作用已得到广泛研究。已知白细胞介素 4(IL-4)和白细胞介素 13(IL-13)可诱导慢性瘙痒。同样,白细胞介素 31(IL-31)在特应性皮炎和结节性痒疹等临床情况下诱导瘙痒的直接作用也已得到证实。此外,白细胞介素 4 受体α抗体(度普利尤单抗)和白细胞介素 31 受体 A 抗体(奈莫利尤单抗)可抑制瘙痒。然而,这些白细胞介素在瘙痒中的相互作用尚不清楚。因此,我们研究了这些细胞因子在小鼠瘙痒中的相互作用。白细胞介素 31 的皮内给药以剂量依赖性方式诱导瘙痒相关的搔抓行为。有趣的是,当观察 30 分钟、2 小时、24 小时或 48 小时时,IL-31 和 IL-4/IL-13 的共同给药或 IL-4/IL-13 的 30 分钟预给药以及 IL-4 的皮内或静脉内预给药均不会影响 IL-31 诱导的瘙痒相关搔抓行为。针对 IL-4 和 IL-13 的中和抗体的预给药也不会影响 IL-31 诱导的瘙痒相关搔抓行为。这些结果表明,白细胞介素 31 可在体内独立于白细胞介素 4 和白细胞介素 13 诱导瘙痒。

相似文献

1
IL-4 and IL-13 are not involved in IL-31-induced itch-associated scratching behaviour in mice.白细胞介素-4 和白细胞介素-13 不参与白细胞介素-31 诱导的小鼠瘙痒相关搔抓行为。
Exp Dermatol. 2024 Jun;33(6):e15115. doi: 10.1111/exd.15115.
2
Cynomolgus monkey model of interleukin-31-induced scratching depicts blockade of human interleukin-31 receptor A by a humanized monoclonal antibody.白细胞介素-31 诱导搔抓的食蟹猴模型描述了人源化单克隆抗体对人白细胞介素-31 受体 A 的阻断作用。
Exp Dermatol. 2018 Jan;27(1):14-21. doi: 10.1111/exd.13236. Epub 2017 Apr 10.
3
Interleukin-4 and interleukin-13 evoke scratching behaviour in mice.白细胞介素-4 和白细胞介素-13 可诱发小鼠搔抓行为。
Exp Dermatol. 2019 Dec;28(12):1501-1504. doi: 10.1111/exd.14034. Epub 2019 Oct 1.
4
Interleukin Profiling in Atopic Dermatitis and Chronic Nodular Prurigo.特应性皮炎和慢性结节性痒疹的白细胞介素谱分析。
Int J Mol Sci. 2024 Aug 2;25(15):8445. doi: 10.3390/ijms25158445.
5
A single dose of interleukin-31 (IL-31) causes continuous itch-associated scratching behaviour in mice.单次白细胞介素-31(IL-31)给药可导致小鼠持续瘙痒相关抓挠行为。
Exp Dermatol. 2013 Oct;22(10):669-71. doi: 10.1111/exd.12222.
6
Oncostatin M suppresses expression in dorsal root ganglia and interleukin-31-induced itching.抑瘤素 M 抑制背根神经节中的表达和白细胞介素-31 诱导的瘙痒。
Front Immunol. 2023 Nov 16;14:1251031. doi: 10.3389/fimmu.2023.1251031. eCollection 2023.
7
Nemolizumab: An Innovative Biologic Treatment to Control Interleukin 31, a Key Mediator in Atopic Dermatitis and Prurigo Nodularis.尼莫利珠单抗:一种创新性的生物制剂,用于控制白细胞介素 31,这是特应性皮炎和结节性痒疹的关键介质。
Actas Dermosifiliogr. 2022 Jul-Aug;113(7):674-684. doi: 10.1016/j.ad.2021.12.014. Epub 2021 Dec 23.
8
Nemolizumab efficacy in prurigo nodularis: onset of action on itch and sleep disturbances.尼莫利珠单抗治疗结节性痒疹的疗效:对瘙痒和睡眠障碍的起效时间。
J Eur Acad Dermatol Venereol. 2022 Oct;36(10):1820-1825. doi: 10.1111/jdv.18377. Epub 2022 Jul 4.
9
Nalbuphine, a kappa opioid receptor agonist and mu opioid receptor antagonist attenuates pruritus, decreases IL-31, and increases IL-10 in mice with contact dermatitis.纳布啡是一种κ阿片受体激动剂和μ阿片受体拮抗剂,可减轻接触性皮炎小鼠的瘙痒,降低 IL-31 并增加 IL-10。
Eur J Pharmacol. 2019 Dec 1;864:172702. doi: 10.1016/j.ejphar.2019.172702. Epub 2019 Sep 27.
10
Interleukin-31 Receptor A Expression in the Dorsal Root Ganglion of Mice with Atopic Dermatitis.特应性皮炎小鼠背根神经节中白细胞介素 31 受体 A 的表达。
Int J Mol Sci. 2023 Jan 5;24(2):1047. doi: 10.3390/ijms24021047.

引用本文的文献

1
Four Cases of Prurigo Nodularis Requiring Nemolizumab due to Persistent Pruritus or Lesions after Dupilumab Treatment.4例结节性痒疹在度普利尤单抗治疗后因持续性瘙痒或皮损而需要使用奈莫利单抗治疗
Acta Derm Venereol. 2025 Jun 16;105:adv43419. doi: 10.2340/actadv.v105.43419.
2
Macrophages in inflammatory skin diseases and skin tumors.炎症性皮肤病和皮肤肿瘤中的巨噬细胞。
Front Immunol. 2024 Dec 5;15:1430825. doi: 10.3389/fimmu.2024.1430825. eCollection 2024.